Publicacións en colaboración con investigadores/as de Hospital Vall d'Hebron (17)

2024

  1. Chronic Obstructive Lung Disease: Treatment Guidelines and Recommendations for Referral and Multidisciplinary Continuity of Care

    Journal of Clinical Medicine, Vol. 13, Núm. 2

  2. Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project

    Respiratory Research, Vol. 25, Núm. 1

2023

  1. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

    BMC Health Services Research, Vol. 23, Núm. 1

  2. Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry

    The European respiratory journal

  3. Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin

    International Journal of COPD, Vol. 18, pp. 1691-1700

2022

  1. ANTES Program: One Year on

    Archivos de Bronconeumologia

  2. Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity

    Archivos de Bronconeumologia, Vol. 58, Núm. 2, pp. 135-141

2021

  1. Outcomes of surgical resection after neoadjuvant chemoimmunotherapy in locally advanced stage IIIA non-small-cell lung cancer

    European Journal of Cardio-thoracic Surgery, Vol. 60, Núm. 1, pp. 81-88

  2. Spanish Implementation of the New International Alpha-1 Anitrypsin Deficiency International Registry: The European Alpha-1 Research Collaboration (EARCO)

    Archivos de Bronconeumologia

  3. Utility of transient elastography for the screening of liver disease in patients with alpha1-antitrypsin deficiency

    Journal of Clinical Medicine, Vol. 10, Núm. 8

2020

  1. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey

    Respiratory Medicine, Vol. 170

  2. New cis-acting variants in PI∗S background produce null phenotypes causing alpha-1 antitrypsin deficiency

    American Journal of Respiratory Cell and Molecular Biology, Vol. 63, Núm. 4, pp. 444-451

2018

  1. Alpha-1 antitrypsin deficiency: Outstanding questions and future directions

    Orphanet Journal of Rare Diseases, Vol. 13, Núm. 1

2017

  1. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease

    Journal of the American Medical Directors Association, Vol. 18, Núm. 12, pp. 1097.e11-1097.e24

  2. Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial

    The Lancet Respiratory Medicine, Vol. 5, Núm. 4, pp. 259-268

2016

  1. Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients

    Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 29, Núm. 2, pp. 142-152

2014

  1. Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems

    Health and Quality of Life Outcomes, Vol. 12, Núm. 1